Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Anticuerpos Primarios

Anti-Vatreptacog alfa Recombinant Antibody (4F5) (HY060033)

Anti-Vatreptacog alfa Recombinant Antibody (4F5)
Anti-Vatreptacog alfa Recombinant Antibody (4F5)
Precio(USD):
Especificación:
  • 50ug
  • 100ug
  • 1mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHY060033
Reactividad de especiesHuman
AplicacionesELISA, FuncS, SPR
Especie huéspedMouse
ClonalidadMonoclonal
IsotipoIgG2a, kappa
ID de clon4F5
Objetivo F7, Coagulation factor VII, FVII, Proconvertin, Serum prothrombin conversion accelerator, SPCA, Eptacog alfa, mutant version of FVIIa, FVIIaDVQ, Vatreptacog alfa, hFVIIa, rFVIIa analog NN1731
Nivel de endotoxinas < 10 EU/mg
Pureza >95% as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso P08709
RRID Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Antibody (4F5) (abinScience Cat# HY060033, RRID:AB_3727168)
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Información de uso del producto
Aplicación Dilución
ELISA 1:2000-1:20000
Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Nombres alternativosVatreptacog alfa
Fondo

Coagulation factor VII (FVIIa Mutant Version (FVIIaDVQ)) is a ~51 kDa protein. Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa also converts factor IX to factor IXa in the presence of tissue factor and calcium.

1. Osterud, B. et al. (1977) Proceedings of the National Academy of Sciences of the United States of America 74, 5260-4. PMID: 271951
Nota For research use only.
Imágenes
  • Anti-Vatreptacog alfa Recombinant Antibody (4F5)

    SDS-PAGE

    SDS-PAGE for Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Antibody (4F5)

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores